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Abstract
Histone deacetylase (HDAC) inhibitors are being intensively pursued as potential new drugs for a range of diseases,
including malaria. HDAC inhibitors are also important tools for the study of epigenetic mechanisms, transcriptional control,
and other important cellular processes. In this study the effects of three structurally related antimalarial HDAC inhibitors on
P. falciparum malaria parasite gene expression were compared. The three hydroxamate-based compounds, trichostatin A
(TSA), suberoylanilide hydroxamic acid (SAHA; VorinostatH) and a 2-aminosuberic acid derivative (2-ASA-9), all caused
profound transcriptional effects, with ,2–21% of genes having .2-fold altered expression following 2 h exposure to the
compounds. Only two genes, alpha tubulin II and a hydrolase, were up-regulated by all three compounds after 2 h exposure
in all biological replicates examined. The transcriptional changes observed after 2 h exposure to HDAC inhibitors were
found to be largely transitory, with only 1–5% of genes being regulated after removing the compounds and culturing for a
further 2 h. Despite some structural similarity, the three inhibitors caused quite diverse transcriptional effects, possibly
reflecting subtle differences in mode of action or cellular distribution. This dataset represents an important contribution to
our understanding of how HDAC inhibitors act on malaria parasites and identifies alpha tubulin II as a potential
transcriptional marker of HDAC inhibition in malaria parasites that may be able to be exploited for future development of
HDAC inhibitors as new antimalarial agents.
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Introduction
Transcriptional control in malaria parasites is relatively poorly
understood, however there is increasing evidence that targeting
DNA replication/transcriptional regulation represents a potential
new therapeutic approach for malaria [1,2]. Enzymes involved in
gene expression and regulation in Plasmodium falciparum, the most
lethal of the malaria parasites that infect humans, are now
beginning to be characterised and their biological roles defined.
Histone modification enzymes, including P. falciparum histone
deacetylases (PfHDACs), are recognised new drug targets for
malaria [1,3]. PfHDACs, together with histone acetyltransferases
(PfHATs), reversibly modify the e-amino groups of lysine residues
on the N-terminal regions of histones, thereby contributing to
regulation of chromatin-structure dynamics. To date, five putative
HDAC-encoding genes have been identified in the P. falciparum
genome. Two are homologues of the human Silent Information
Regulator 2 (Sir2)-related proteIN (sirtuin) family (class III
HDACs). Although the PfSir2 proteins have been shown to be
involved in regulating transcription of some P. falciparum virulence
proteins, neither of these class III HDACs is essential for parasite
survival in vitro [4,5,6]. Of the other three PfHDACs, little is
known about their biological function, however the class I HDAC
homologue (PfHDAC1) has recently been shown to be a target of
antimalarial HDAC inhibitors [7].
Pan-inhibitors of both class I and II HDACs, such as the cyclic
tetrapeptide apicidin and the hydroxamate trichostatin A (TSA),
have potent antimalarial activity in vitro (Figure 1) [8]. These
compounds cause hyperacetylation of P. falciparum histones,
indicating inhibition of one or more PfHDACs [8]. Unfortunately,
both apicidin and TSA suffer from metabolic instability and
neither is parasite-selective (Figure 1), so without modifications
that overcome these problems, both are unsuitable antimalarial
drugs. To address these issues, second generation hydroxamate-
based compounds are now being pursued, some of which have
similar in vitro potency against P. falciparum as TSA (IC50,50 nM)
but, importantly, have improved in vitro selectivity in killing
parasites over host cells (Figure 1) [9,10]. Like TSA, these
compounds are known inhibitors of HDACs, cause hyperacetyla-
tion of P. falciparum histones, and inhibit deacetylase activity in P.
falciparum nuclear extracts [9,10]. Despite this indication of mode
of action in the parasite, little is known about subsequent effects of
such hydroxamate-based antimalarial compounds on P. falciparum
gene expression. Such information may be important not only to
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identifying molecular markers to aid in the development of drugs
to specifically target transcription in P. falciparum.
To begin to address this, we recently carried out a genome wide
gene expression survey to examine the effect of 20 antimalarial
compounds, including apicidin and TSA, on P. falciparum intra-
erythrocytic developmental stages, the life cycle stage that is
responsible for the clinical symptoms associated with malaria [11].
TSA and apicidin caused a general deregulation of the intra-
erythrocytic developmental cycle transcriptional cascade (,30–
60% of the genome). This dramatic effect was not seen with other
antimalarial compounds, including protease inhibitors, kinase
inhibitors, and the antimalarial drug chloroquine. These findings
of large scale transcriptional alterations by HDAC inhibitors are
not surprising, and mirror affects seen with these compounds in
higher eukaryotic cells [12,13]. However, as discussed above, both
apicidin and TSA have poor parasite-specific selectivity (Figure 1;
SI,30), raising the question as to whether they act against
parasites in the same way as more parasite-selective antimalarial
HDAC inhibitors. In this study, we investigated this by examining
the genome wide transcriptional effects of TSA and two other
hydroxamate-based compounds, suberylanilide hydroxamic acid
(SAHA; VorinostatH) and an analogue of 2-aminosuberic acid (2-
ASA-9) [14] in P. falciparum parasites. Both compounds have
potent in vitro activity against P. falciparum, but better selectivity
than apicidin or TSA at the whole cell level for P. falciparum
compared to mammalian cells (Figure 1). In comparing the
transcriptional affects of these compounds, we identified alpha
tubulin II as a gene that is commonly up-regulated by all three
hydroxamate HDAC inhibitors, but not other antimalarial
compounds. We propose that this gene represents a signature of
HDAC inhibition in P. falciparum that will assist in the development
of this class of compounds as antimalarials. Furthermore, we
examined whether transcriptional changes caused by the three
HDAC inhibitors result in long-lasting or transitory effects, so as to
better understand temporal gene regulation in the parasite.
Figure 1. In vitro profile of different HDAC inhibitors.
doi:10.1371/journal.pone.0031847.g001
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Genome wide effect of three hydroxamate-based HDAC
inhibitors on P. falciparum transcription
To examine the effect of different hydroxamate-based HDAC
inhibitors on the P. falciparum transcriptome, 3D7 trophozoite-
stage parasites (,32–36 h post invasion) were treated with
DMSO (vehicle control), SAHA, TSA, or 2-ASA-9 at their
IC90 concentrations for 2 h (termed 2 h+). Cells were then
harvested for preparation of RNA and microarray analysis. To
determine if alterations were transitory, parallel cultures were also
treated for 2 h and the compounds then removed by washing,
followed by culturing of the cells for a further 2 h (termed 2 h+/
2h 2). Cells were harvested, RNA prepared and microarray
analysis carried out. Two independent biological replicates were
preformed and overall, expression data was obtained for 3,942
genes. Using a 2-fold change in expression as a cut-off, parasites
exposed to SAHA, TSA, and 2-ASA-9 for 2 h showed modulated
transcription levels of 10–21%, 11–17%, and 2–7% of genes,
respectively, for two independent biological replicates (Figure 2;
File S1). Microarray data of the biological replicates was
compared by calculating Pearson Correlation Coefficients for
the DMSO-subtracted data. The two 2 h+ biological replicate
data sets presented a significant positive correlation of 0.71 and
0.61 (p-value,0.0005), for TSA and SAHA, respectively.
Considering the fact that transcriptional changes induced by
HDAC inhibitors represent combinations of the direct and
indirect effect on histone modifications in the genome [15], the
obtained correlation values indicate a good reproducibility
between the two biological replicates. Similarly, the 2-ASA-9
2h + replicates showed a good reproducibility where in both cases
only a handful of genes were consistently up-regulated (Figure 2).
For further evaluation of the reproducibility between the
biological replicas, we carried out additional microarray assays
with the 0 h DMSO control samples (starting cultures of the two
biological replicas). First, each 0 h DMSO sample was hybridized
Figure 2. Global transcriptional response of P. falciparum to hydroxamate-based HDAC inhibitors. Synchronous 3D7 trophozoite-stage
parasites were treated with DMSO (0.05%) or IC90 amounts of SAHA, TSA, or 2-ASA-9. RNA was collected from parasites after treatment for 2 h (2 h+),
or after 2 h, washing, and culture for a further 2 h (2 h+/2 h2). cDNA was synthesized from RNA and labelled with Cy5 and hybridized against Cy3
labelled 3D7 reference pool. Microarray data, including mRNA abundance ratios between each sample and the 3D7 reference pool, was filtered as
described in material and methods. Data shown are genes with .2 fold differential expression induced by the compounds. Heat map showing up-
(red), down- (green) regulated or relatively unchanged (black) genes, for two independent biological replicates for each compound (A). The total
number of genes with altered expression is shown graphically (B) and genes commonly or uniquely regulated in 2 h+ or 2 h+2h 2 parasites are
shown in Venn diagrams (C). For (B) and (C) data are the combined replicates for each compound to show genes commonly up- or down-regulated
for each compound and treatment time. For example, 127 genes were up-regulated in common between both biological replicates for parasites
treated with SAHA for 2 h (B).
doi:10.1371/journal.pone.0031847.g002
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developmental cycle stages in order to confirm the level of
synchronicity in these starting cultures. Comparative analysis
showed high levels of correlations between these two microarray
results (regression coefficient 0.74 and Pearson correlation
coefficient 0.86) which confirm the high level of synchronicity
of both starting cultures. In addition, the two 0 h DMSO samples
were compared directly by comparative microarray hybridiza-
tions including a dye swap experiments (2 microarrays for each
swap) in order to assess the progression of the developmental
stages in the two starting cultures and technical reproducibility of
the microarray analyses. Similarly, the average regression
coefficient 0.81 (60.09) and absolute value of the Pearson
correlation coefficient 0.9 (60.05) indicate good biological and
technical consistency of all transcriptomic analyses presented in
this study. Data analyses below focus on effects that were in
common between different pairs of compounds, or in common to
all three compounds
Short term exposure to hydroxamate HDAC inhibitors
results in transient regulation of P. falciparum gene
expression
To investigate whether transcriptional alterations caused by
short-term (non-lethal) exposure to hydroxamate HDAC inhibi-
tors is long lasting or transitory; the effect of the three different
HDAC inhibitors was compared after 2 h exposure or after 2 h
exposure followed by washing to remove compounds and an
additional 2 h culture (2 h+2h 2). First, Western blot with an
anti-(tetra) acetyl-H4 antisera was used to examine in situ
acetylation of P. falciparum histone H4. As expected, all three
HDAC inhibitors, but not DMSO vehicle, caused hyperacetyla-
tion of histone H4 following 2 h or 4 h continual exposure to the
compounds. In contrast, the H4 acetylation state returned from a
hyperacetylated state in 2 h+ parasites, to a similar level as the
controls in 2 h+/2 h2 parasites (Figure 3).
Next the genome-wide transcriptional changes in 2 h+ versus
2h +/2 h2 parasites were examined. The total number of genes
with altered expression in 2 h+2h 2 parasites was ,1–5% of
genes on the array, compared to ,2–21% in 2 h+ parasites,
depending on the compound being examined (2-fold cut off; File
S1). Of the genes that were up- or down-regulated after 2 h
exposure to SAHA, more than 85% were no longer regulated .2-
fold after washing off the compound and culturing for a further
2 h (File S2). For TSA and 2-ASA-9, more than 80% and ,70%
of genes, respectively, that were .2-fold regulated in 2 h+
parasites, were no longer regulated in 2 h+/2 h2 parasites (File
S2).
Hydroxamate HDAC inhibitors regulate a small common
gene set in P. falciparum
Only two genes, alpha tubulin II (PFD1050w) and a putative
hydrolase/phosphatase (PFL1260w), were commonly up-regulated
by TSA, SAHA and 2-ASA-9 in all replicates after 2 h exposure to
the compounds (Figure 2C). This was the case using both a 2- and
3-fold cut-off. Alpha tubulin II, but not the hydrolase/phospha-
tase, was also .2-fold up-regulated by all three compounds in
2h +/2 h2 samples. No genes were commonly down-regulated by
the three compounds. The up-regulation of alpha tubulin II and
the putative hydrolase/phosphatase was confirmed using quanti-
tative RT-PCR (Figure 4). The expression of three additional
genes was also examined by RT-PCR. Serine repeat antigen 2
(SERA-2; PFB0355c), which was up-regulated .2-fold in at least
one replicate for all three inhibitors in microarrays experiments,
was also up-regulated by all compounds in quantitative RT-PCR,
but only .2-fold by SAHA. PF13_0142 (putative U6 snRNA-
associated Sm-like protein (LSm6)) and PFE0150c (putative 4-
diphosphocytidyl-2c-methyl-D-erythritol kinase (CMK)) were
down-regulated approximately .1.5–2-fold in at least one 2 h+
replicate by SAHA, TSA or 2-ASA-9 treatment in microarray
experiments. Both genes were also down-regulated by quantitative
RT-PCR (Figure 4).
In order to investigate the possibility that alpha tubulin II and
the putative hydrolase/phosphatase might represent transcription-
al markers of HDAC inhibition in P. falciparum, we examined the
expression of these genes in other publically available P. falciparum
microarray data sets. In our previous microarray study showing P.
falciparum transcriptional changes following exposure to 20
different compounds, alpha tubulin II was up-regulated following
exposure to TSA and the cyclic tetrapeptide HDAC inhibitor
apicidin [16]. However, in most samples the putative hydrolase/
phosphatase was not up-regulated by these two HDAC inhibitors
(File S3). Strikingly, with the exception of staurosporine which up-
regulated the putative hydrolase/phosphatase in some samples,
neither gene was up-regulated in parasites treated with 18 non-
HDAC inhibitor compounds (File S3) [11,15]. Likewise, neither
alpha tubulin II nor the putative hydrolase/phosphatase was
amongst small sets of genes differentially regulated in 3D7
parasites exposed to chloroquine [17] or the dihydrofolate
reductase inhibitor WR99210 [18]. In P. falciparum parasites
exposed to artesunate [19] or heat stressed [20], alpha tubulin II
gene transcription was not regulated compared to controls,
however the putative hydrolase/phosphatase transcript was up-
regulated. In another study, alpha tubulin II expression was not
changed in parasites exposed to the choline inhibitor T4 for 5 h
(,26 or ,206IC50)o r1 8h( ,1256IC50). While this gene was
Figure 3. Histone H4 hyperacetylation assay. P. falciparum 3D7 infected erythrocytes were cultured in vitro with IC90 concentrations of TSA,
SAHA or 2-ASA-9 for 2 h (2 h+), for 2 h followed by washing and culture for a further 2 h (2 h+/2 h2), or for 4 h (4 h+). Matched control cultures,
including a control taken at the start of the experiment (C-0 h) received vehicle only. Parasite protein lysates were prepared and separated via SDS-
PAGE, followed by Western blot analysis using anti-(tetra) acetyl histone H4 or anti-GAPDH antisera as a loading control.
doi:10.1371/journal.pone.0031847.g003
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high (406 IC50) amounts of the compound [21], it is difficult to
make any direct comparisons of these data with our own given that
T4 has been previously shown to act rapidly on both ring and
trophozoite stage P. falciparum parasites (.85% inhibition
following 1 h exposure to ,20–406 IC50 T4) [22]. While the
effects of compound kinetics, such as the time taken to reach a
given compounds target, need to be considered, our data suggest
that alpha tubulin II may be a transcriptional marker of HDAC
inhibition in the parasite.
As discussed above, alpha tubulin II was the only gene that was
up-regulated by all HDAC inhibitor treatments in our current
study and previous studies, but not by short term exposure to other
antimalarial compounds. As our microarray and quantitative RT-
PCR data was carried out using a chloroquine-sensitive line (3D7),
the expression of alpha tubulin II was assessed in a different line to
determine if the expression of this gene was also up-regulated in
drug resistant parasites. In Northern blot analysis of RNA from P.
falciparum K1 parasites, an increase in transcript was detected using
an alpha tubulin II-specific probe in parasites treated with TSA,
SAHA, and 2-ASA-9, but not the antimalarial drug chloroquine
(Figure 5).
Clusters of genes are differentially regulated by different
HDAC inhibitors
Even though the three HDAC inhibitors tested in this study are
all hydroxamates, there were still a number of differences in the
expression changes observed. When data from the two biological
replicates for each compound were combined, one cluster of genes
had greater than 2-fold increased expression after 2 h treatment
with SAHA or TSA but was not up-regulated by 2-ASA-9.
Functional pathway analysis of this gene set was carried out
against the Gene Ontology (GO) and Malaria Parasite Metabolic
Pathways (MPMP) however only one pathway (‘‘cellular protein
metabolic process’’; p=0.01), had more than 2 genes over-
represented (File S4).
Another cluster of genes that showed differential expression in
the combined biological replicates are those that were down-
regulated more than 2-fold by SAHA and TSA, but not by 2-ASA-
9 exposure (Figure 2). Pathways significantly over-represented with
more than two genes being present in this gene set include the
‘‘nuclear genes with apicoplast signal sequences’’ pathway (p=0.02) and
the ‘‘nuclear genes with mitochondrial signal’’ pathway (p=0.04) (File
S4).
Each individual 2 h+ replicate was also examined for functional
pathways that were significantly over-represented (p,0.05) using
the Malaria Parasite Metabolic Pathway (File S5). In at least one
replicate for each compound, merozoite invasion-related protein
pathways were found to be significantly over-represented in both
up-regulated and down-regulated gene sets. This result is similar to
our previous finding in that trophozoite-stage parasites exposed to
the non-hydroxamate based HDAC inhibitor apicidin increased
transcription of genes belonging to the functional group ‘‘subcellular
localization of proteins involved in invasion’’ that are normally expressed
in schizonts [15]. The ‘‘Sphingomyelin and ceramide metabolism’’
pathway was also significantly over-represented in all replicates
of the up-regulated gene set (except 2-ASA-9 replicate 1) with four
genes being represented: a longevity-assurance (LAG1) domain
protein (PFE0405c), a long chain fatty acid elongation enzyme
(PFI0980w), dolichol phosphate mannose synthase (PF11_0427),
and serine C-palmitoyltransferase (PF14_0155). None of the other
pathways were over-represented for more than two replicates for
any compound in the up-regulated gene set. Likewise, for the
down-regulated gene-sets most of the pathways over-represented
were not in common between the compounds and replicates,
although as discussed below, there were some similarities for TSA
and SAHA.
Gene sets only regulated only in 2 h+2h 2 parasites were also
analysed for functionally enriched pathways. Few trends, in terms
Figure 4. Validation of up- and down-regulated gene expres-
sion by quantitative PCR. Quantitative RT-PCR was carried out on
five genes using RNA obtained from cells treated with DMSO or
compound for 2 h (2 h+). PFD1050w (alpha tubulin II) and PFL1260w
(putative hydrolase/phosphatase) were up-regulated in both biological
replicates for each compound in microarray analyses; PFB0355c (SERA2)
was up-regulated in at least one biological replicate for each
compound; and PF13_0142 (a putative spliceosome component) and
PFE0150c (a putative kinase) were both down regulated at least one
replicate for TSA and SAHA, but not regulated by 2-ASA-9. Relative fold
change in expression levels were calculated using 2
2DDCt method
where histone H4 gene was used as internal control.
doi:10.1371/journal.pone.0031847.g004
Figure 5. Effect of HDAC inhibitor treatment on transcription
of P. falciparum alpha tubulin II and histone H4 genes.
Synchronous trophozoite-stage K1 P. falciparum infected erythrocytes
were treated with ,16IC50 or ,56IC50 concentrations of chloroquine
(0.5 and 2.5 mM), TSA (20 and 100 nM), SAHA (100 and 500 nM), or 2-
ASA-9 (40 and 200 nM) for 2 hours. Matched controls taken at 0 h and
2 h (C-0 h and C-2 h, respectively) were treated with 0.05% dimethyl
sulfoxide (DMSO). Total RNA was prepared and separated via
electrophoresis on an 1.0% agarose gel, followed by transfer and
crosslinking to nitrocellulose membrane. The membrane was probed
with
32P-labeled alpha tubulin II purified PCR product, then stripped
and re-probed with
32P-labeled histone H4 gel purified PCR product.
The histone H4 transcript and ethidium bromide-stained agarose gel is
shown to indicate RNA loading levels.
doi:10.1371/journal.pone.0031847.g005
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replicates are apparent although as in 2 h+ parasites (above)
merozoite invasion related pathways were represented (File S6).
Discussion
HDAC inhibitors are being pursued as new drugs for a range of
diseases including infectious diseases such as malaria. Despite
several studies demonstrating that different HDAC inhibitors have
potent in vitro activity against Plasmodium parasites, we still know
little about how these compounds exert their anti-parasitic affect.
The aim of this study was therefore to try to better understand the
effects of hydroxamate-based compounds, one of the best studied
antimalarial HDAC inhibitor classes [1], on P. falciparum
transcription. The three inhibitors tested were TSA, SAHA, and
2-ASA-9, a 2-aminosuberic acid-based compound. As shown in
Figure 1, all three compounds have potent in vitro activity against
P. falciparum parasites, but different levels of parasite-specific
selectivity. Overall, the compounds altered the expression of
between ,2–21% of genes in P. falciparum trophozoite-stage
parasites after 2 h exposure. This level of transcriptional
regulation is similar to that obtained in previous studies using
mammalian cell lines where, depending on the HDAC inhibitor
and/or cell line used, transcription of 2–22% of genes was altered
[12,13,23]. The changes caused by the hydroxamate compounds
in this study were, however, lower than those we recently observed
for a non-hydroxamate HDAC inhibitor, apicidin, which
regulated ,41% of genes after 2 h exposure [15]. It remains to
be determined if these overall differences are due to experimental
variation, compounds-related effect such as cell permeability, or
even differences in molecular target(s) within the parasite.
All three hydroxamates tested in this study caused both up- and
down-regulation of genes compared to the controls in at least one
replicate (Figure 2). Down-regulation of gene expression might
appear to be counter-intuitive given that HDAC inhibitors cause
hyperacetylation of histones in the parasite which should lead to
transcriptional activation, however similar findings have been
previously reported [12,15]. Down-regulation of gene expression
by HDAC inhibitors may be the result of acetylation of histones
not normally acetylated at a particular time, therefore blocking
access of transcription machinery, or due to transcription of
regulatory factors that in turn negatively regulate transcription of
other genes [12]. In addition, HDACs are also known to target
non-histone proteins in mammalian cells, including transcription
factors, cytoskeletal proteins, and nuclear import factors [24]. This
may have an indirect effect on transcription of some genes.
However, it is not yet known if HDACs target non-histone
proteins in Plasmodium parasites and so we can only speculate at
this stage on what affects this might have following HDAC
inhibitor treatment of the parasite.
An interesting finding resulting from this study was that only
two genes were commonly regulated by all three HDAC
inhibitors, in all treatments and replicates. The genes are alpha
tubulin II, which is normally expressed in asexual stage parasites,
sporozoites and male gametocytes stages [25], and a putative
hydrolase/phosphatase that is normally expressed in gametocyte
and sporozoite stage parasites [26]. The normal transcription
levels of these two genes was recently confirmed using RNA-Seq of
seven different time points across the asexaul stage life cycle, with
alpha tubulin II, but not the putative hydrolase/phosphatise, being
expressed [27]. Comparison of our data with other microarray
data showed that the expression of the putative hydrolase/
phosphatase is altered by treatment with HDAC inhibitors as well
as some other antimalarial compounds. In contrast, transcription
of alpha tubulin II was not affected by short term treatment with
non-HDAC inhibitor compounds including the antimalarial drug
chloroquine (Figure 5) [11,17]. While our finding that such a small
set of genes are commonly regulated by HDAC inhibitors in P.
falciparum may seem surprising, it is similar to a previous study
using three different carcinoma cell lines. In that study, just 13 of
,6,800 genes were regulated more than 2-fold (8 up and 5 down)
by TSA, SAHA, and another HDAC inhibitor (MS-275; human
HDAC-1 selective) [12]. While we speculate that alpha tubulin II
may be a transcriptional signature of HDAC inhibition in P.
falciparum, additional work is required to confirm this. The
compounds used in this study are all known to be pan-HDAC
inhibitors as they inhibit the activity of multiple class I and II
HDAC isoforms in mammalian cells. Therefore additional studies
should include determining if other classes of HDAC inhibitors
(e.g, class III HDAC inhibitors) and compounds with different
HDAC isoform selectivities also up-regulate alpha tubulin II
expression. Likewise, additional studies on the Plasmodium stage-
specific effects of HDAC inhibitors on alpha tubulin II expression
will be of interest, as will studies on possible effects at the protein
level. If alpha tubulin II is confirmed as being a transcriptional
marker of HDAC inhibitor action in P. falciparum, it may be
possible use this, together with other assays such as histone
hyperacetylation, as an additional marker for identifying and
developing new lysine deacetylase inhibitors for malaria.
In order to better understand the pharmacodynamic action of
HDAC inhibitors on malaria parasites, we compared the
transcriptional changes occurring following short exposure to the
three HDAC inhibitors versus a treatment where parasites were
washed and returned to culture. The majority of the changes
(,70% or more) that occurred after 2 h exposure to these
compounds were transitory. The concentrations of HDAC
inhibitors (IC90) and exposure times (2 h) used in this study were
selected to be sub-lethal, to try to rule out effects that might be due
to cell death. Continual exposure of P. falciparum parasites to
HDAC inhibitors does kill parasites [10], however stage specific
growth inhibition assays carried out as part of this study show a
slight, but not significant, effect on growth of trophozoite-stage
parasites treated with SAHA or 2-ASA-9 if the compounds are
washed off after 2 h and the parasites returned to culture (File S7).
Together, our data indicate that transcriptional control in the
malaria parasite is altered by exposure to small molecule HDAC
inhibitors that may modify chromatin structure and transcription.
It is, however, difficult to confirm whether the different effects are
due to differences in physiochemical properties (e.g. ability to
permeate cells) or to specific changes due to target-based effects.
Despite being related in chemical structure and in their influence
on the transcription of two specific genes, overall the three
compounds caused very different transcriptional changes. The
precise reason for this is unclear. All three compounds cause
hyperacetylation of P. falciparum histones [8,9,10] (Figure 3),
supporting their role as inhibitors of P. falciparum HDAC enzymes.
At the molecular level, all three compounds share a common zinc-
binding hydroxamate, and similar linker regions that connect this
zinc-binding ligand to the ‘‘capping’’ group, but different
components at the other end of the molecule. SAHA and TSA
have a single aromatic functional group, while 2-ASA-9 has two
aromatic groups in this region (File S8). These changes in chemical
composition likely influence the binding of these compounds to
target proteins. In silico molecular modeling studies in which TSA,
SAHA and 2-ASA-9 were docked into a three dimensional
homology model structure of PfHDAC1 [10], suggest that the
three different capping groups likely all bind in a pocket adjacent
to the entrance to the catalytic active site of PfHDAC1. The
HDAC Inhibitors and P. falciparum Transcription
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pocket in the protein surface adjacent to the entrance of the
catalytic active site. 2-ASA-9 also differs from TSA and SAHA, in
that its amide-NHs can interact via H-bonding with Asp97 at the
top of the active site tunnel, which has been suggested to be critical
for inhibitor binding [28].
It is also possible that the three compounds differentially inhibit
P. falciparum HDAC enzymes, which might account for different
gene expression profiles in the parasite, although non-specific
effects might also be possible. TSA and SAHA, while pan-
inhibitors of human HDACs, have recently been found to exhibit
different inhibitory profiles against individual human HDAC
enzymes [29]. Once all recombinant P. falciparum HDAC enzymes
become available, it will be important to profile these and other
HDAC inhibitors for their specificities on malaria parasite
HDACs. There may also be other differences in the action of
these compounds against non-histone proteins of the parasite that
are yet to be determined. In higher eukaryotic cells, numerous
non-histone proteins are now known to be associated with
HDACs, including transcription factors, cytoskeletal proteins,
and nuclear import factors [24]. Human HDACs are known to
deacetylate lysine residues of numerous proteins involved in gene
expression [30]. Indeed one proteomic analysis of three human
cell lines identified over a thousand nuclear and non-nuclear
proteins that were modified by lysine acetylation at thousands of
individual sites [31].
Finally, the pharmacokinetic and pharmacodynamic properties
of these three HDAC inhibitors have not yet been fully evaluated.
However, TSA, SAHA and 2-ASA-9 do have CLogP values
spanning 2 log units (1.9, 1.0, and 2.9, respectively; Figure 1)
suggesting very different lipophilicities that may translate into
different cell membrane permeability, different intracellular
distributions of inhibitors in the cytosol and nucleus, and different
partitioning into organelles.
In summary, in this study three structurally related HDAC
inhibitors (TSA, SAHA, and a 2-aminosuberic acid derivative, 2-
ASA-9) have been profiled for their effects on gene expression in P.
falciparum parasites. Each compound was found to cause genome-
wide transcriptional changes, consistent with attenuation of
HDAC activity in the parasite. Although impacting on up to
21% of P. falciparum genes, many of these transcriptional changes
were transitory, highlighting the dynamic nature of transcription
in the malaria parasite in response to small molecule inhibitors
that target chromatin structure. Despite being related in chemical
structure, the three inhibitors had very different overall effects on
gene expression profiles in P. falciparum. Only a small set of two
genes were up-regulated by all three HDAC inhibitors. One of
these, alpha tubulin II, may represent the first recognized
signature of transcriptional change induced by HDAC inhibitors
in P. falciparum and could potentially be utilized in functional assays
for developing the next generation of improved HDAC inhibitors
for malaria. Together these findings provide new insights into the
pharmacodynamic effects of a promising new class of antimalarial
compounds in P. falciparum parasites.
Materials and Methods
Compounds
The synthesis, purification and characterization of the 2-
aminosuberic acid derivative 2-ASA-9 have been previously
described [14]. TSA and SAHA were purchased from Sigma-
Aldrich (St. Louis, MO). All compounds were prepared as 10 mM
stock solutions in DMSO and stored at 220uC.
P. falciparum culture and treatment
P. falciparum parasites were cultured in vitro essentially as
previously described [10,32]. Treatment of P. falciparum infected
erythrocytes with HDAC inhibitors was carried out using
synchronous trophozoite-stage parasites (,32–36 h post invasion)
at 5% parasitemia and 5% hematocrit. Two independent
biological replicates were prepared for each compound and
matched controls. Trophozoite-stage parasites were used in this
study as this intraerythrocytic stage is more susceptible to SAHA
and 2-ASA-9 than ring stage parasites (File S7). Cultures were
treated with compound vehicle (0.05% DMSO), and to ensure
that differential effects of the three compounds could be
compared, ,IC90 concentrations of compounds were used
(SAHA, 200 nM, TSA 50 nM, and 2-ASA-9 80 nM), rather than
a standard concentration. The IC90 concentrations were deter-
mined using an in vitro
3H-hypoxanthine uptake assay, as
previously described [10]. At these concentrations, we have
previously shown ,90% of parasites will be killed in growth
assays after 24 h exposure [10]. However, File S7 shows that there
was no significant reduction in parasitemia compared to controls
24 h after P. falciparum parasites were exposed to SAHA or 2-ASA-
9 for only 2 h. In this study, cells were treated for 2 h then
harvested (termed 2 h+). In parallel, after 2 h exposure to
compound, a second matched replicate was washed gently twice
in 10 pellet volumes of pre-warmed parasite culture media and
returned to culture for a further 2 h (termed 2 h+/2 h2). Controls
that were only exposed to compound vehicle (0.05% DMSO) were
harvested at the beginning of the experiment and at the same time
points as the test compounds. This percentage of DMSO has been
previously shown to have no effect on P. falciparum transcription
[11]. No morphological changes were apparent in any samples
after these exposure times, as determined by microscopic
examination (not shown). Prior to isolating RNA, cells were
washed once in PBS then stored at 280uC in TrizolH reagent.
Samples were processed for microarray analysis as previously
described [15], and RNA quality confirmed via agarose gel
electrophoresis.
Microarray analysis
Expression profiling was carried out using a long oligonucleo-
tide platform representing all 5,363 P. falciparum genes as
previously described [33]. We have previously demonstrated that
the technical variability of this microarray platform is within the
standards of other microarray technologies reaching a high
confidence level (.95%) [11,34] and that fluorophore-related
effects are minimal and do not exceed the general level of
confidence of microarray technology [34]. cDNA synthesis and
labelling was carried out as described [33] and Cy5 labelled cDNA
was hybridized against Cy3 labelled 3D7 reference pool. The data
was normalized using Lowess method [35] and processed to filter
out spots with at least 95% pixels having signal intensity within 2
standard deviations from background for both Cy5 and Cy3
fluorescence. Each gene profile was represented by an average
expression value calculated as an average of all spots representing
a particular gene. Hierarchical clustering [36] was carried out in
Gene Cluster and visualized using Java Treeview [37]. Processed
microarray data are shown in File S9. Microarray data has been
submitted and assigned GEO accession number GSE25642. An
analysis of correlation between the microarray results of biological
replicates was performed using Graphpad Prism Version 5
(Graphpad Software Inc.). First it was determined whether the
data were distributed normally, using the ‘‘D’Agostino & Pearson
omnibus normality test’’. This test indicated that the data were not
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(Rho) was employed. All methods used an alpha value of 0.05.
Hyperacetylation assay
Hyperacetylation assays were carried out as previously de-
scribed [9,10] using protein lysates prepared from synchronous
trophozoite-stage P. falciparum 3D7 parasites cultured in vitro with
IC90 concentrations of TSA, SAHA or 2-ASA-9. Cultures were
incubated continually for 2 h (2 h+), for 2 h followed by washing
and culture for a further 2 h (2 h+/2 h2), or continually for 4 h
(4 h+). Matched control cultures, including a control taken at the
start of the experiment (C-0 h) received vehicle only (0.05%
DMSO). Infected erythrocytes were lysed with 0.15% saponin
(Sigma), parasite pellets washed extensively in phosphate buffered
saline pH 7.4 to remove haemoglobin, then pellets resuspended in
16SDS-PAGE loading buffer. Protein extracts were separated via
SDS-PAGE then Western blot analysis carried out. Hyperacety-
lated histone H4 was detected using anti-(tetra) acetyl histone H4
anti-sera (Upstate, Millipore) and loading controlled using anti-
PfGAPDH antisera.
Quantitative PCR
Microarray data were confirmed using quantitative PCR of
selected genes on 7500 Real Time PCR System from Applied
Biosystems using the Power SYBR Green PCR Master Mix
(Applied Biosystems, Life Technologies; California, USA) accord-
ing to manufacturer’s instructions. Ct (threshold cycle) values for
each target gene under drug treatment were normalized to the
expression level of the respective control condition. Relative fold
change in expression levels of these genes under drug treatment
was calculated using 2
2DDCt method where histone H4 gene was
used as internal control. All PCR reactions were carried out in
triplicates using samples from biological replicate 1. Primer pairs
used were: 59-atg aga gaa gtc att agt att cat gtt gga-39 and 59-aac
ttc gtc aac gac ggt ggg ttc taa atc-39 (PFD1050w); 59-tgt taa aac aca
aat ata acg att cat gtg-39 and 59- atc ata acc ttt cat atg aat ata agc
acc a-39 (PFL1260w); 59-aag agt gaa acc act aca gat gaa tct gc-39
and 59 ata ctt ctg cac ctg gtc ttg ctg att cta-39 (PFB0355c); 59-gtg
gaa agt tta aa agg tcg agc agt aat t-39 and 59-ctg tta att cac cat cat
aat att ctt cag-39 (PF13_0142); and 59-gca tgt gga tat gta cgt tta aat
aat gag-39 and: 59-gaa tgc att aag gtt gat act tca tta tat g-39
(PFE0150c).
Northern blot
Synchronous trophozoite stage K1 P. falciparum infected
erythrocytes (chlorquine- and pyrimethamine-sensitive) [38] were
treated with ,16IC50 and ,56IC50 concentrations of chloro-
quine (K1 IC50 ,350–590 nM [39,40,41]), HDAC inhibitors
(,IC50s determined based on data in Figure 1), or vehicle alone
(0.05% DMSO), for 2 h. Cells were washed once in 10 pellet
volumes of cold PBS, lysed in 0.15% saponin for 5 min on ice,
centrifuged and the parasite pellet resuspended in 10 volumes of
TrizolH reagent. Samples were stored at 280uC prior to isolating
RNA and carrying out Northen blot analysis, as previously
described [42]. PCR products were generated using gene specific
primers to alpha tubulin II (59-gta cca cgt tgt gtg ttc g-39 and 59-
tca ttc ata tcc ctc atc ttc tcc-39) and histone H4 (59-atg tca gga aga
ggt aag g-39 and 59-acc tcc aaa acc ata taa agt tct tcc-39). PCR
products were labelled with
32P-a-dCTP (Perkin-Elmer, USA)
using a Hexa-prime labelling kit (Fermentas, USA) and
hybridization carried out at 42uC overnight. Membranes were
washed twice at 60uCi n0 . 5 6 SSC and 0.1% SDS before
autoradiography.
Supporting Information
File S1 Number of genes regulated by HDAC inhibitors
(.2 fold).
(PDF)
File S2 Venn diagrams showing numbers of genes
regulated uniquely and commonly in 2 h+ and
2h +2h 2 parasites. Individual biological replicates for SAHA
(A&B), TSA (D&E), and 2-ASA-9 (G&H) are shown. Combined
replicate data (box) is shown in C (SAHA), F (TSA), and I (2-
ASA-9. Only alpha tubulin II (PFD1050w) was up-regulated in
every treatment, treatment time, and replicate. Alpha tubulin II,
and two hypothetical proteins (MAL8P1.4 and PF11_0479),
were commonly up-regulated in each replicate and treatment
time for TSA and SAHA. Alpha tubulin II, c14rRNA.3-5s, and a
putative hydrolase/phosphatise (PFL1260w) were commonly up-
regulated in each replicate and treatment time for SAHA 2-
ASA-9. Alpha tubulin II was the only gene commonly up-
regulated for every treatment time and replicate between TSA
and 2-ASA-9. No genes were commonly down-regulated in any
sample.
(PDF)
File S3 Gene expression data for alpha tubulin II
(PFD1050w) and a putative hydrolase/phosphatase
(PFL1260w) in P. falciparum parasites treated at
different asexual developmental stages with 20 antima-
larial compounds. Data are extracted from our previously
published work [16]. Black bar shows $2-fold increased transcript
detected compared to matched controls for each time point and
replicate tested.
(PDF)
File S4 Excel spreadsheet showing functional pathway
analysis of genes commonly up-regulated or down-
regulated in 2 h+ parasites treated with SAHA and
TSA, but not 2-ASA-9.
(XLS)
File S5 Functional pathway analysis of genes up-
regulated (A) or down-regulated (B) in 2 h+ parasites.
The numbers of genes in pathways significantly over-represented
(p,0.05) for each biological replicate for parasites treated with
SAHA (red bars), TSA (blue bars) and 2-ASA-9 (black bars) is
shown.
(PDF)
File S6 Functional pathway analysis of genes up-
regulated (A) or down-regulated (B) only in 2 h+2h 2
parasites. The numbers of genes in pathways significantly over-
represented (p,0.05) for each biological replicate for parasites
treated with SAHA (red bars), TSA (blue bars) and 2-ASA-9 (black
bars) is shown.
(PDF)
File S7 Stage-specific effect of short exposure of HDAC
inhibitors on P. falciparum infected erythrocytes. Syn-
chronous ring (A and C) and trophozoite (B and D) stage P.
falciparum infected erythrocytes were treated with 25 nM, 125 nM,
or 250 nM SAHA or 2-ASA-9 for 2 h (black bars) or 4 h (white
bars) followed by washing and assessing parasite growth 48 h later.
Percentage growth (6 standard deviation) relative to untreated
DMSO controls is shown for 4–5 independent assays. Asterisk
indicates a significant difference in % growth compared to
untreated control cultures (p,0.05).
(PDF)
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xamate HDAC inhibitors TSA (A), SAHA (B), and 2-ASA-9
(C) showing the zinc binding group (ZBG), linker region,
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File S9 Excel spreadsheet of microarray data.
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